The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,796.00
Bid: 1,788.00
Ask: 1,796.00
Change: -50.00 (-2.71%)
Spread: 8.00 (0.447%)
Open: 1,882.00
High: 1,882.00
Low: 1,762.00
Prev. Close: 1,846.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

20 Nov 2019 07:00

RNS Number : 9637T
Genus PLC
20 November 2019
 

For Immediate Release 20 November 2019

 

Genus plc('Genus', or the 'Company')

Appointment of Chief Financial Officer

Genus plc (LSE: GNS), a leading global animal genetics company, is pleased to announce that Alison Henriksen has been appointed by the Board as Chief Financial Officer with effect from 13 January 2020.

Alison Henriksen has over 25 years of international experience in finance, operating across Europe, Australia, Asia, the US and South Africa. She has a proven track record of driving performance in public and privately held organisations, both business to business and business to consumer facing.

Alison is currently the Chief Financial Officer of V. Group, a global leader in ship management and based in the UK. Her past appointments include Finance Director, UK & Ireland and Finance Director, Australia at Compass Group plc, and Chief Financial Officer of Specialty Fashion Group Ltd, a former ASX listed company. She started her career at Ernst and Young in her native Australia and, after qualifying as a chartered accountant, spent nine years in their London practice, the majority of which was in Corporate Finance, supporting clients with M&A transactions.

Stephen Wilson, Chief Executive of Genus, commented on Alison's appointment;

"I am delighted to welcome Alison as Chief Financial Officer to Genus. She brings deep commercial and financial expertise across a wide range of industries, as well as extensive M&A experience. I am confident that Alison will help drive Genus in the next stage of our continued growth, and the implementation of our strategic vision."

Genus

Tel: +44(0)1256 345970

Stephen Wilson, Chief Executive

Buchanan

Tel: +44(0)207 466 5000

Charles Ryland /Chris Lane / Vicky Hayns

This announcement is available on the Genus website www.genusplc.com

About Genus

Genus is a world-leading animal genetics company. Genus creates advances to animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.

Genus's worldwide sales are made in over seventy-five countries under the trademarks 'ABS' (dairy and beef cattle) and 'PIC' (pigs) and comprise semen, embryos and breeding animals with superior genetics to those animals currently in farms. Genus's customers' animals produce offspring with greater production efficiency, and quality, and use these to supply the global dairy and meat supply chains.

The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.

With headquarters in Basingstoke, United Kingdom, Genus companies operate in over twenty-five countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

Regulatory Notes

Details of payments to be made to Alison Henriksen will be disclosed in full in the Company's 2020 Directors' Remuneration Report. Any such terms will be consistent with the Company's Directors' Remuneration Policy approved by shareholders at its Annual General Meeting on 14 November 2019.

 

This announcement is made in accordance with Listing Rule 9.6.11R. There are no matters to be disclosed in connection with Listing Rule 9.6.13R (2) - (6).

 

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014. The person responsible for making this announcement on behalf of the Group is Dan Hartley (General Counsel and Company Secretary).

 

As previously announced, Janet Duane has been acting as the Company's interim Group Finance Director. Janet will revert to her role as Group Financial Controller upon Alison Henriksen's appointment and will support Alison's transition. Janet will cease to be a Person Discharging Managerial Responsibility with effect from 13 January 2020.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFERLFLALIA
Date   Source Headline
27th Oct 20112:00 pmRNSAnnual Information Update
11th Oct 201111:39 amRNSAnnual Report and Annual General Meeting
30th Sep 20112:44 pmRNSTotal Voting Rights
22nd Sep 20112:33 pmRNSHolding(s) in Company
20th Sep 20113:08 pmRNSAdditional Listing
20th Sep 20113:07 pmRNSDirector/PDMR Shareholding
9th Sep 201111:00 amRNSDirector/PDMR Shareholding
6th Sep 20117:00 amRNSPreliminary Results
31st Aug 20112:00 pmRNSTotal Voting Rights
29th Jul 20112:00 pmRNSBlocklisting Interim Review
29th Jul 20112:00 pmRNSTotal Voting Rights
4th Jul 20117:00 amRNSPre-close Trading Statement
25th May 20117:00 amRNSCEO Retirement and Appointment of Successor
12th May 20112:08 pmRNSHolding(s) in Company
11th May 20117:00 amRNSInterim Management Statement
28th Apr 20112:00 pmRNSTotal Voting Rights
31st Mar 20112:00 pmRNSTotal Voting Rights
10th Mar 20115:56 pmRNSHolding(s) in Company
9th Mar 201111:00 amRNSDirector Shareholding
28th Feb 20112:37 pmRNSTotal Voting Rights
22nd Feb 20117:00 amRNSInterim Results
31st Jan 20112:00 pmRNSBlocklisting Interim Review
31st Jan 20112:00 pmRNSTotal Voting Rights
27th Jan 20113:57 pmRNSNotice of Results
21st Jan 20113:36 pmRNSHolding(s) in Company
30th Nov 20102:00 pmRNSTotal Voting Rights
26th Nov 20104:27 pmRNSHolding(s) in Company
11th Nov 20103:33 pmRNSResult of AGM
11th Nov 20107:00 amRNSAGM and IMS
29th Oct 20102:30 pmRNSTotal Voting Rights
28th Oct 20107:00 amRNSStrategic Progress in India
27th Oct 20102:30 pmRNSAnnual Information Update
14th Oct 201010:00 amRNSAnnual Financial Report and AGM Meeting
30th Sep 20103:30 pmRNSTotal Voting Rights
27th Sep 20102:30 pmRNSDirector/PDMR Shareholding
22nd Sep 20103:16 pmRNSAdditional Listing
22nd Sep 20102:49 pmRNSDirector/PDMR Shareholding
15th Sep 20102:50 pmRNSDirector/PDMR Shareholding
13th Sep 201011:00 amRNSDirector/PDMR Shareholding
10th Sep 20102:00 pmRNSDirector/PDMR Shareholding
7th Sep 20107:01 amRNSBoard Change
7th Sep 20107:00 amRNSPreliminary Results
30th Jul 20102:00 pmRNSBlocklisting Interim Review
5th Jul 20107:00 amRNSPre-Close Trading Statement
17th Jun 20102:30 pmRNSHolding(s) in Company
3rd Jun 20103:30 pmRNSDirector's Shareholding
12th May 20107:00 amRNSInterim Management Statement
30th Apr 20102:00 pmRNSTotal Voting Rights
19th Apr 20102:58 pmRNSHolding(s) in Company
7th Apr 20102:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.